Eurofins Scientific SE (HAM:ESF0) ROCE %: 9.23% (As of Dec. 2025)

What is Eurofins Scientific SE ROCE %?

Eurofins Scientific SE HAM:ESF0 +2.80% 87 ROCE % is 9.23% as of Dec. 2025. GuruFocus rates HAM:ESF0 with a GF Score™ of 87/100 and a GF Value™ of €66.78 (Fairly Valued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Eurofins Scientific SE's annualized ROCE % for the quarter that ended in Dec. 2025 was 9.23%.

Eurofins Scientific SE (HAM:ESF0) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Eurofins Scientific SE ROCE % Related Terms

Eurofins Scientific SE ROCE % Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE ROCE % Chart

Eurofins Scientific SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

16.04

11.22

6.47

8.04

9.36

Eurofins Scientific SE Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROCE %	Get a 7-Day Free Trial															6.35	8.51	7.40	9.67	9.23

87GF Score

Eurofins Scientific SE HAM:ESF0

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Eurofins Scientific SE ROCE % Calculation

Eurofins Scientific SE's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	811.2	/	( ( (10888.4 - 2110.2)	+	(10985.4 - 2429.6) )	/ 2 )
	=	811.2	/	( (8778.2	+	8555.8)	/ 2 )
	=	811.2	/	8667
	=	9.36 %

Eurofins Scientific SE's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	787.4	/	( ( (10585.9 - 2085.4)	+	(10985.4 - 2429.6) )	/ 2 )
	=	787.4	/	( ( 8500.5	+	8555.8 )	/ 2 )
	=	787.4	/	8528.15
	=	9.23 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 9.23% mean?

Eurofins Scientific SE (HAM:ESF0) has a ROCE % of 9.23% as of Dec. 2025.

Is Eurofins Scientific SE's ROCE % too high?

Eurofins Scientific SE's current ROCE % is 9.23%. Overall, Eurofins Scientific SE has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Eurofins Scientific SE's ROCE % compare to TMO and DHR?

Eurofins Scientific SE's ROCE % of 9.23% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Diagnostics & Research company?

A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. Eurofins Scientific SE's current ROCE % is 9.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Eurofins Scientific SE stock overvalued right now?

Based on GuruFocus' analysis, Eurofins Scientific SE (HAM:ESF0) is currently considered Fairly Valued. The stock's GF Value™ is €66.78, compared to a current price of €66.88 — trading 0.1% above its estimated fair value. The current ROCE % is 9.23%. Eurofins Scientific SE's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Eurofins Scientific SE (HAM:ESF0), the current ROCE % is 9.23% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (HAM:ESF0) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued. The current stock price of €66.88 is trading 0.1% above its estimated GF Value™ of €66.78. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for HAM:ESF0:

ROCE %: 9.23%
GF Value™: €66.78 vs. price of €66.88 (0.1% above fair value)
GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the HAM:ESF0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurofins Scientific SE Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies XPAR:BIM XPAR:LBIRD XPAR:ALECR XPAR:ALKLH XPAR:ALPRE TMO DHR SHSE:603259 XSWX:LONN IDXX A WAT NTRA IQV ILMN MTD DGX LH GH MEDP

Other Exchanges ERFSF:USA ERFp:UK 0MV5:UK ERF:France ESF0:Germany ESF:Austria

Address 23 Val Fleuri, Luxembourg, LUX, 1526

Website https://www.eurofins.com

Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.

87GF Score

Get the complete analysis for HAM:ESF0

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€66.88

Price

€66.78

GF Value

View HAM:ESF0 Analysis

See ROCE % data for all stocks →